Wai Chun Bio-Tech (660) Announces Board Meeting to Review Interim Results

Bulletin Express

02/12

Wai Chun Bio-Technology Limited (Stock Code: 660) has scheduled a board meeting on 27 February 2026 at Rooms 4001–02, 40th Floor, China Resources Buildings, 26 Harbour Road, Wanchai, Hong Kong. According to the announcement dated 12 February 2026, the meeting will focus on considering and approving the unaudited interim results for the six months ended 31 December 2025, as well as the publication of those results.

The board of Wai Chun Bio-Technology Limited currently comprises one executive director, Chairman and Chief Executive Officer, Mr. Lam Ka Chun, alongside three independent non-executive directors: Mr. Wong Po Keung, Mr. Wang Ziniu, and Ms. Xu Huiling.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1138575770"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1138575770\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1138575770?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-12 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138575770","market":"us","top_or_hot":-1,"title":"Wai Chun Bio-Tech (660) Announces Board Meeting to Review Interim Results","media":"Bulletin Express","content":"<p>Wai Chun Bio-Technology Limited (Stock Code: 660) has scheduled a board meeting on 27 February 2026 at Rooms 4001–02, 40th Floor, China Resources Buildings, 26 Harbour Road, Wanchai, Hong Kong. According to the announcement dated 12 February 2026, the meeting will focus on considering and approving the unaudited interim results for the six months ended 31 December 2025, as well as the publication of those results.</p>\n<p>The board of Wai Chun Bio-Technology Limited currently comprises one executive director, Chairman and Chief Executive Officer, Mr. Lam Ka Chun, alongside three independent non-executive directors: Mr. Wong Po Keung, Mr. Wang Ziniu, and Ms. Xu Huiling.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wai Chun Bio-Tech (660) Announces Board Meeting to Review Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWai Chun Bio-Tech (660) Announces Board Meeting to Review Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-12 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wai Chun Bio-Technology Limited (Stock Code: 660) has scheduled a board meeting on 27 February 2026 at Rooms 4001–02, 40th Floor, China Resources Buildings, 26 Harbour Road, Wanchai, Hong Kong. According to the announcement dated 12 February 2026, the meeting will focus on considering and approving the unaudited interim results for the six months ended 31 December 2025, as well as the publication of those results.</p>\n<p>The board of Wai Chun Bio-Technology Limited currently comprises one executive director, Chairman and Chief Executive Officer, Mr. Lam Ka Chun, alongside three independent non-executive directors: Mr. Wong Po Keung, Mr. Wang Ziniu, and Ms. Xu Huiling.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00660","symbol_name":"玮俊生物科技","start_time":0,"source_url":"","article_id":"1138575770","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138575770","pubTimestamp":1770885937,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Wai Chun Bio-Technology Limited (Stock Code: 660) has scheduled a board meeting on 27 February 2026 at Rooms 4001–02, 40th Floor, China Resources Buildings, 26 Harbour Road, Wanchai, Hong Kong....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00660":"玮俊生物科技"},"translate_title":"伟俊生物(660)公布董事会会议审阅中期业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00660":1},"content_text":"Wai Chun Bio-Technology Limited (Stock Code: 660) has scheduled a board meeting on 27 February 2026 at Rooms 4001–02, 40th Floor, China Resources Buildings, 26 Harbour Road, Wanchai, Hong Kong. According to the announcement dated 12 February 2026, the meeting will focus on considering and approving the unaudited interim results for the six months ended 31 December 2025, as well as the publication of those results.\nThe board of Wai Chun Bio-Technology Limited currently comprises one executive director, Chairman and Chief Executive Officer, Mr. Lam Ka Chun, alongside three independent non-executive directors: Mr. Wong Po Keung, Mr. Wang Ziniu, and Ms. Xu Huiling.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}